PACIFIC VIEW ASSET MANAGEMENT, LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 185 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.

Quarter-by-quarter ownership
PACIFIC VIEW ASSET MANAGEMENT, LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q2 2019$463,000
+17.2%
4,925
+0.0%
0.50%
+22.4%
Q1 2019$395,000
+49.6%
4,924
-0.0%
0.41%
+32.3%
Q4 2018$264,000
-28.6%
4,925
+4.1%
0.31%
+5.4%
Q3 2018$370,000
+20.5%
4,732
-2.0%
0.29%
+21.0%
Q2 2018$307,000
-11.5%
4,830
+27.2%
0.24%
-6.9%
Q1 2018$347,0003,7960.26%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q2 2018
NameSharesValueWeighting ↓
TRV GP II, LLC 878,875$70,354,00045.87%
CVI Holdings, LLC 200,000$16,010,00015.16%
Foresite Capital Management III, LLC 467,682$37,438,0009.74%
Casdin Capital, LLC 848,648$67,934,0007.46%
BVF INC/IL 564,965$45,225,0005.06%
Ghost Tree Capital, LLC 240,000$19,212,0005.02%
DAFNA Capital Management LLC 119,718$9,583,0004.13%
HHLR ADVISORS, LTD. 1,498,516$119,956,0003.34%
Opaleye Management Inc. 130,000$10,407,0002.88%
Perceptive Advisors 1,271,054$101,748,0002.87%
View complete list of BLUEPRINT MEDICINES CORP shareholders